• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

考克兰专论:恶性胸腔积液处理的干预措施。

Cochrane corner: interventions for the management of malignant pleural effusions.

机构信息

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.

International Observatory on End of Life Care, Lancaster University, Lancaster, UK.

出版信息

Thorax. 2016 Oct;71(10):964-6. doi: 10.1136/thoraxjnl-2016-208989. Epub 2016 Jul 14.

DOI:10.1136/thoraxjnl-2016-208989
PMID:27418604
Abstract

Optimal management of symptomatic malignant pleural effusions remains an important issue as it affects a significant number of patients each year internationally. The overall survival remains poor, necessitating an evidence based treatment strategy that provides the best outcomes for individual patients. This paper summarises the results of the recently published Cochrane review on interventions in malignant pleural effusions.

摘要

症状性恶性胸腔积液的最佳管理仍是一个重要问题,因为它每年在国际上影响大量患者。总体生存率仍然较差,需要有循证治疗策略,为每个患者提供最佳结果。本文总结了最近发表的 Cochrane 综述中关于恶性胸腔积液干预措施的结果。

相似文献

1
Cochrane corner: interventions for the management of malignant pleural effusions.考克兰专论:恶性胸腔积液处理的干预措施。
Thorax. 2016 Oct;71(10):964-6. doi: 10.1136/thoraxjnl-2016-208989. Epub 2016 Jul 14.
2
Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis.留置胸膜导管与胸膜固定术治疗恶性胸腔积液。系统评价和荟萃分析。
Ann Am Thorac Soc. 2019 Jan;16(1):124-131. doi: 10.1513/AnnalsATS.201807-495OC.
3
Interventions for the management of malignant pleural effusions: a network meta-analysis.恶性胸腔积液管理的干预措施:一项网状荟萃分析。
Cochrane Database Syst Rev. 2016 May 8;2016(5):CD010529. doi: 10.1002/14651858.CD010529.pub2.
4
Interventions for the management of malignant pleural effusions: a network meta-analysis.恶性胸腔积液管理的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2020 Apr 21;4(4):CD010529. doi: 10.1002/14651858.CD010529.pub3.
5
Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.澳大利亚恶性胸腔积液(AMPLE)-3 试验:一项多中心随机研究的研究方案,比较留置胸腔导管(±滑石粉胸膜固定术)与电视辅助胸腔镜手术治疗恶性胸腔积液。
Trials. 2022 Jun 27;23(1):530. doi: 10.1186/s13063-022-06405-7.
6
Pleurodesis for malignant pleural effusions.恶性胸腔积液的胸膜固定术
Cochrane Database Syst Rev. 2004(1):CD002916. doi: 10.1002/14651858.CD002916.pub2.
7
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.恶性胸腔积液的处理。美国胸科学会/胸外科学会/胸外科医师学会临床实践指南官方版。
Am J Respir Crit Care Med. 2018 Oct 1;198(7):839-849. doi: 10.1164/rccm.201807-1415ST.
8
Pleurodesis for malignant pleural effusions: current controversies and variations in practices.恶性胸腔积液的胸膜固定术:当前的争议与实践差异
Curr Opin Pulm Med. 2004 Jul;10(4):305-10. doi: 10.1097/01.mcp.0000129756.87090.55.
9
Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.胸腔镜下胶原胸膜固定术治疗恶性胸腔积液
Eur J Cardiothorac Surg. 2005 Nov;28(5):750-3. doi: 10.1016/j.ejcts.2005.07.015. Epub 2005 Sep 29.
10
Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.留置胸膜导管与滑石粉胸膜固定术对恶性胸腔积液患者住院天数的影响:AMPLE随机临床试验
JAMA. 2017 Nov 21;318(19):1903-1912. doi: 10.1001/jama.2017.17426.

引用本文的文献

1
Risk factors related to pleural empyema after talc slurry pleurodesis.滑石粉胸膜固定术后脓胸的相关危险因素。
Clinics (Sao Paulo). 2022 Aug 27;77:100098. doi: 10.1016/j.clinsp.2022.100098. eCollection 2022.
2
Surgical Diagnosis of Malignant Pleural Mesothelioma: 20 Years' Experience at a High-Volume Referral Center.恶性胸膜间皮瘤的外科诊断:在一家高容量转诊中心的20年经验
J Clin Med. 2021 May 4;10(9):1973. doi: 10.3390/jcm10091973.
3
Performance of Xpert® MTB/RIF in diagnosing tuberculous pleuritis using thoracoscopic pleural biopsy.
Xpert® MTB/RIF 在经胸腔镜胸膜活组织检查诊断结核性胸膜炎中的表现。
BMC Infect Dis. 2020 Nov 12;20(1):840. doi: 10.1186/s12879-020-05578-3.
4
Viscum pleurodesis is as effective as talc pleurodesis and tends to have less adverse effect.槲寄生胸膜固定术与滑石粉胸膜固定术效果相同,且不良反应较少。
Support Care Cancer. 2020 Nov;28(11):5463-5467. doi: 10.1007/s00520-020-05405-0. Epub 2020 Mar 12.
5
Prognostic Factors of Malignant Pleural Effusion among Palliative Care Outpatients: A Retrospective Study.姑息治疗门诊患者恶性胸腔积液的预后因素:一项回顾性研究
Indian J Palliat Care. 2018 Apr-Jun;24(2):184-188. doi: 10.4103/IJPC.IJPC_183_17.
6
Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions.复发性恶性胸腔积液管理策略的质量差距和比较效果。
Chest. 2018 Feb;153(2):438-452. doi: 10.1016/j.chest.2017.08.026. Epub 2017 Aug 31.
7
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.恶性胸膜间皮瘤:调查、诊断与治疗的最新进展
Eur Respir Rev. 2016 Dec;25(142):472-486. doi: 10.1183/16000617.0063-2016.